Healthcare >> CEO Interviews >> March 18, 2022
Jay Venkatesan, M.D., is the President, Chief Executive Officer, and Chairman of Angion Biomedica Corp. Prior to Angion, Dr. Venkatesan served as President and Director of Alpine Immune Sciences (ALPN), which he co-founded as a Managing Partner of Alpine BioVentures. Previously, Dr. Venkatesan was the founder and portfolio manager of Ayer Capital, a global health care fund. Prior to that, he served as a director at Brookside Capital, part of Bain Capital, where he co-managed health care investments. He was also a consultant at McKinsey & Co. and a venture investor with Patricof & Co. Ventures (now Apax Partners). He received his M.D. from the University of Pennsylvania School of Medicine, his MBA from the Wharton School of the University of Pennsylvania, and his B.A. from Williams College. Profile
Word count: 3,772
TWST: Let’s start with an overview of the company and its mission.
Dr. Venkatesan: The company was founded more than 20 years ago to target